These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 24588559)

  • 21. Therapeutic use of cannabis.
    de Vries K; Green AJ
    Nurs Times; 2012 Feb 28-Mar 5; 108(9):12-5. PubMed ID: 22479766
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A new cannabinoid CB2 receptor agonist HU-910 attenuates oxidative stress, inflammation and cell death associated with hepatic ischaemia/reperfusion injury.
    Horváth B; Magid L; Mukhopadhyay P; Bátkai S; Rajesh M; Park O; Tanchian G; Gao RY; Goodfellow CE; Glass M; Mechoulam R; Pacher P
    Br J Pharmacol; 2012 Apr; 165(8):2462-78. PubMed ID: 21449982
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cannabinoids and bone: endocannabinoids modulate human osteoclast function in vitro.
    Whyte LS; Ford L; Ridge SA; Cameron GA; Rogers MJ; Ross RA
    Br J Pharmacol; 2012 Apr; 165(8):2584-97. PubMed ID: 21649637
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Redox-based therapeutics in neurodegenerative disease.
    McBean GJ; López MG; Wallner FK
    Br J Pharmacol; 2017 Jun; 174(12):1750-1770. PubMed ID: 27477685
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Emerging areas of opioid pharmacology.
    Kelly E; Henderson G; Bailey CP
    Br J Pharmacol; 2018 Jul; 175(14):2715-2716. PubMed ID: 29939423
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The proteostasis network provides targets for neurodegeneration.
    Newton TM; Duce JA; Bayle ED
    Br J Pharmacol; 2019 Sep; 176(18):3508-3514. PubMed ID: 30820936
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sex as a biological variable in the pathology and pharmacology of neurodegenerative and neurovascular diseases.
    Honarpisheh P; McCullough LD
    Br J Pharmacol; 2019 Nov; 176(21):4173-4192. PubMed ID: 30950038
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Δ8-Tetrahydrocannabivarin prevents hepatic ischaemia/reperfusion injury by decreasing oxidative stress and inflammatory responses through cannabinoid CB2 receptors.
    Bátkai S; Mukhopadhyay P; Horváth B; Rajesh M; Gao RY; Mahadevan A; Amere M; Battista N; Lichtman AH; Gauson LA; Maccarrone M; Pertwee RG; Pacher P
    Br J Pharmacol; 2012 Apr; 165(8):2450-61. PubMed ID: 21470208
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cannabidivarin is anticonvulsant in mouse and rat.
    Hill AJ; Mercier MS; Hill TD; Glyn SE; Jones NA; Yamasaki Y; Futamura T; Duncan M; Stott CG; Stephens GJ; Williams CM; Whalley BJ
    Br J Pharmacol; 2012 Dec; 167(8):1629-42. PubMed ID: 22970845
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evidence for using cannabis and cannabinoids to manage pain.
    Wood S
    Nurs Times; 2004 Dec 7-13; 100(49):38-40. PubMed ID: 15630971
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neutralization of IL-17 rescues amyloid-β-induced neuroinflammation and memory impairment.
    Cristiano C; Volpicelli F; Lippiello P; Buono B; Raucci F; Piccolo M; Iqbal AJ; Irace C; Miniaci MC; Perrone Capano C; Calignano A; Mascolo N; Maione F
    Br J Pharmacol; 2019 Sep; 176(18):3544-3557. PubMed ID: 30673121
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of non-euphoric plant cannabinoids on muscle quality and performance of dystrophic mdx mice.
    Iannotti FA; Pagano E; Moriello AS; Alvino FG; Sorrentino NC; D'Orsi L; Gazzerro E; Capasso R; De Leonibus E; De Petrocellis L; Di Marzo V
    Br J Pharmacol; 2019 May; 176(10):1568-1584. PubMed ID: 30074247
    [TBL] [Abstract][Full Text] [Related]  

  • 33. GPR18 in microglia: implications for the CNS and endocannabinoid system signalling.
    McHugh D
    Br J Pharmacol; 2012 Dec; 167(8):1575-82. PubMed ID: 22563843
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cannabinoid CB1 receptors transactivate multiple receptor tyrosine kinases and regulate serine/threonine kinases to activate ERK in neuronal cells.
    Dalton GD; Howlett AC
    Br J Pharmacol; 2012 Apr; 165(8):2497-511. PubMed ID: 21518335
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cannabinoids.
    López-Rodríguez ML
    Mini Rev Med Chem; 2005 Jul; 5(7):607. PubMed ID: 16026306
    [No Abstract]   [Full Text] [Related]  

  • 36. Anti-inflammatory effects of cannabinoid CB(2) receptor activation in endotoxin-induced uveitis.
    Toguri JT; Lehmann C; Laprairie RB; Szczesniak AM; Zhou J; Denovan-Wright EM; Kelly ME
    Br J Pharmacol; 2014 Mar; 171(6):1448-61. PubMed ID: 24308861
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cannabinoids in health and disease.
    Kogan NM; Mechoulam R
    Dialogues Clin Neurosci; 2007; 9(4):413-30. PubMed ID: 18286801
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The multiplicity of action of cannabinoids: implications for treating neurodegeneration.
    Gowran A; Noonan J; Campbell VA
    CNS Neurosci Ther; 2011 Dec; 17(6):637-44. PubMed ID: 20875047
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunity and hypertension: New targets to lighten the pressure.
    Vinh A; Drummond GR; Sobey CG
    Br J Pharmacol; 2019 Jun; 176(12):1813-1817. PubMed ID: 31127619
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Endocannabinoids and pain: spinal and peripheral analgesia in inflammation and neuropathy.
    Rice AS; Farquhar-Smith WP; Nagy I
    Prostaglandins Leukot Essent Fatty Acids; 2002; 66(2-3):243-56. PubMed ID: 12052040
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.